Jie He

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Top Venues

Signal transduction and targeted therapy

Journal for immunotherapy of cancer

Clinical epigenetics

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ziqin Deng, Tao Fan, Chu Xiao, He Tian, Yujia Zheng, Chunxiang Li, Jie He
TGF-β signaling in health, disease, and therapeutics. Signal transduction and targeted therapy 9 (1) (2024)
Ziqin Deng, Tao Fan, Chu Xiao, He Tian, Yujia Zheng, Chunxiang Li, Jie He
TGF-β signaling in health, disease, and therapeutics. Signal transduction and targeted therapy 9 (1) (2024)
Ziqin Deng, Tao Fan, Chu Xiao, He Tian, Yujia Zheng, Chunxiang Li, Jie He
TGF-β signaling in health, disease, and therapeutics. Signal transduction and targeted therapy 9 (1) (2024)
Tao Fan, Chu Xiao, Hengchang Liu, Yu Liu, Liyu Wang, He Tian, Chunxiang Li, Jie He
CXXC finger protein 1 (CFP1) bridges the reshaping of genomic H3K4me3 signature to the advancement of lung adenocarcinoma. Signal transduction and targeted therapy 8 (1) (2023)
Yujia Zheng, Hao Zhang, Chu Xiao, Ziqin Deng, Tao Fan, Bo Zheng, Chunxiang Li, Jie He
KLF12 overcomes anti-PD-1 resistance by reducing galectin-1 in cancer cells. Journal for immunotherapy of cancer 11 (8) (2023)
Chu Xiao, Tao Fan, Yujia Zheng, He Tian, Ziqin Deng, Jingjing Liu, Chunxiang Li, Jie He
H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy. Journal for immunotherapy of cancer 11 (8) (2023)
Yujia Zheng, Zheng Zhou, Ran Wei, Chu Xiao, Hao Zhang, Tao Fan, Bo Zheng, Chunxiang Li, Jie He
The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating β-catenin. Journal of translational medicine 20 (1) (2022)
Chu Xiao, Tao Fan, He Tian, Yujia Zheng, Zheng Zhou, Shuofeng Li, Chunxiang Li, Jie He
H3K36 trimethylation-mediated biological functions in cancer. Clinical epigenetics 13 (1) (2021)